KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Intangibles: 2013-2024

Historic Intangibles for Emergent BioSolutions (EBS) over the last 12 years, with Dec 2024 value amounting to $501.5 million.

  • Emergent BioSolutions' Intangibles fell 12.57% to $452.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $452.7 million, marking a year-over-year decrease of 12.57%. This contributed to the annual value of $501.5 million for FY2024, which is 11.49% down from last year.
  • According to the latest figures from FY2024, Emergent BioSolutions' Intangibles is $501.5 million, which was down 11.49% from $566.6 million recorded in FY2023.
  • Emergent BioSolutions' 5-year Intangibles high stood at $728.8 million for FY2022, and its period low was $501.5 million during FY2024.
  • For the 3-year period, Emergent BioSolutions' Intangibles averaged around $599.0 million, with its median value being $566.6 million (2023).
  • As far as peak fluctuations go, Emergent BioSolutions' Intangibles climbed by 20.54% in 2022, and later decreased by 22.26% in 2023.
  • Over the past 5 years, Emergent BioSolutions' Intangibles (Yearly) stood at $663.1 million in 2020, then decreased by 8.82% to $604.6 million in 2021, then rose by 20.54% to $728.8 million in 2022, then dropped by 22.26% to $566.6 million in 2023, then dropped by 11.49% to $501.5 million in 2024.